Scott L Pomeroy
Overview
Explore the profile of Scott L Pomeroy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
41647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Jonas O, Calligaris D, Methuku K, Poe M, Francois J, Tranghese F, et al.
J Biomed Nanotechnol
. 2016 Jun;
12(6):1297-302.
PMID: 27319222
Medulloblastoma is the most common childhood malignant brain tumor. The most lethal medulloblastoma subtype exhibits a high expression of the GABAA receptor α5 subunit gene and MYC amplification. New benzodiazepines...
32.
Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford S, Doz F, et al.
Acta Neuropathol
. 2016 Apr;
131(6):821-31.
PMID: 27040285
Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological variables pertaining to age, presence of metastases, extent of resection, histological subtypes and in some instances individual genetic aberrations such...
33.
Hanaford A, Archer T, Price A, Kahlert U, Maciaczyk J, Nikkhah G, et al.
Clin Cancer Res
. 2016 Mar;
22(15):3903-14.
PMID: 27012813
Purpose: We used human stem and progenitor cells to develop a genetically accurate novel model of MYC-driven Group 3 medulloblastoma. We also developed a new informatics method, Disease-model Signature versus...
34.
35.
Ullrich N, Pomeroy S, Kapur K, Manley P, Goumnerova L, Loddenkemper T
Epilepsia
. 2015 Sep;
56(10):1599-604.
PMID: 26332282
Objective: Seizures are common during and after treatment for a primary brain tumor. Our objective was to describe the incidence and risk factors for seizures in long-term survivors of pediatric...
36.
Archer T, Pomeroy S
Cancer Cell
. 2015 May;
27(5):613-5.
PMID: 25965568
Ependymomas have a variable prognosis. In this issue of Cancer Cell, Pajtler and colleagues identify nine subgroups of ependymoma using DNA methylation profiles. Two subgroups, predominately pediatric, are responsible for...
37.
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Zhukova N, Ramaswamy V, Remke M, Martin D, Castelo-Branco P, Zhang C, et al.
Acta Neuropathol Commun
. 2014 Dec;
2:174.
PMID: 25539912
TP53 mutations confer subgroup specific poor survival for children with medulloblastoma. We hypothesized that WNT activation which is associated with improved survival for such children abrogates TP53 related radioresistance and...
38.
Sengupta S, Weeraratne S, Cho Y, Pomeroy S
CNS Oncol
. 2014 Oct;
3(4):245-7.
PMID: 25286034
No abstract available.
39.
He X, Zhang L, Chen Y, Remke M, Shih D, Lu F, et al.
Nat Med
. 2014 Aug;
20(9):1035-42.
PMID: 25150496
Medulloblastoma, the most common malignant childhood brain tumor, exhibits distinct molecular subtypes and cellular origins. Genetic alterations driving medulloblastoma initiation and progression remain poorly understood. Herein, we identify GNAS, encoding...
40.
Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, et al.
Acta Neuropathol
. 2014 May;
128(2):291-303.
PMID: 24839957
Amplification of the C19MC oncogenic miRNA cluster and high LIN28 expression has been linked to a distinctly aggressive group of cerebral CNS-PNETs (group 1 CNS-PNETs) arising in young children. In...